In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 18, 2026), CRCM LP reported 13 stock positions worth $152.1 million . Its top holding was iShares Gold Trust (IAU) at 65.2% of the portfolio, followed by iShares Bitcoin Trust ETF (IBIT, 6.6% ) and Atrium Therapeutics (RNA, 5.7% ). Compared with Q1 2026, it opened 6 new positions, sold out of 1, added to 4 and reduced 2. The biggest buy was a new position in iShares Bitcoin Trust ETF (IBIT) and the biggest sale Burning Rock Biotech Ltd.-ADR (BNR, shares −25% ).
Location SAN FRANCISCO, CA
CIK 0001483234
Portfolio Value $152.1M (Q2 2026) Holdings 13 stocks · $152.1M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q1 2026 IAU iShares Gold Trust 65.22% 1,313,821 $99.2M Add +5.1% IBIT iShares Bitcoin Trust ETF 6.64% 303,555 $10.1M New RNA Atrium Therapeutics Inc. 5.67% 641,539 $8.6M New AIFC AI Financial Corp. filed as AI FINL CORP 4.89% 12,701,530 $7.4M Add +0.7% PLBY Playboy Inc. 4.62% 5,757,807 $7.0M Add +32.5% BTGO Bitgo Holdings Inc. Class A 4.47% 1,312,171 $6.8M New SGOV iShares 0-3 Month Treasury B 3.13% 47,241 $4.8M New VZLA Vizsla Silver Corp. 1.84% 848,216 $2.8M New BNR Burning Rock Biotech Ltd.-ADR 1.17% 211,997 $1.8M Reduce -24.9% PCAP Procap Acquisition Corp. Class A 1.09% 160,656 $1.7M Add +5.4% FRNM Freenome Inc. filed as PERCEPTIVE CAP SOLUTIONS COR 0.70% 97,265 $1.1M Reduce -16.3% TRAX First Tracks Biotherapeutics 0.47% 35,340 $711K New USBC Usbc Inc. 0.11% 555,325 $174K No change
Other holdings (1): bonds, preferreds, convertibles and warrants · $33K (not counted above) Security Class Shares / Principal Value Change PCAPW Procap Acq Corp. A -30 *W EXP 05/16/203 102,735 $33K New
Total filed on the 13F, all lines: $152.2M.
Portfolio Sells Q1 2026 → Q2 2026 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2026 % Of Portfolio Change To Portfolio ▲ BNR Burning Rock Biotech Ltd.-ADR Reduce -24.9% 1.17% −2.09 STAA Staar Surgical Co. Sold out 0.00% −1.32 FRNM Freenome Inc. Reduce -16.3% 0.70% −0.21
Portfolio Buys Q1 2026 → Q2 2026 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2026 % Of Portfolio Change To Portfolio ▼ IBIT iShares Bitcoin Trust ETF New 6.64% +6.64 RNA Atrium Therapeutics Inc. New 5.67% +5.67 BTGO Bitgo Holdings Inc. Class A New 4.47% +4.47 SGOV iShares 0-3 Month Treasury B New 3.13% +3.13 VZLA Vizsla Silver Corp. New 1.84% +1.84 TRAX First Tracks Biotherapeutics New 0.47% +0.47 PCAP Procap Acquisition Corp. Class A Add +5.4% 1.09% −0.01 PLBY Playboy Inc. Add +32.5% 4.62% −0.06 AIFC AI Financial Corp. Add +0.7% 4.89% −5.03 IAU iShares Gold Trust Add +5.1% 65.22% −13.46
Notes & Other Activity Q1 2026 → Q2 2026 Security Class Change vs Q1 2026 Shares / Principal Value ▼ PCAPW Procap Acq Corp. A -30 *W EXP 05/16/203 New 102,735 $33K
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 Amended 13 $152.1M IAU, IBIT, RNA, AIFC, PLBY Q1 2026 8 $141.2M IAU, AIFC, PLBY, BNR, STAA Q4 2025 11 $296.0M GRAL, IAU, HHH, WBD, RNAM Q3 2025 Amended 9 $343.6M IBIT, GRAL, HHH, IAU, AIFC Q2 2025 8 $333.9M GRAL, IBIT, HHH, IAU, CRML Q1 2025 5 $244.0M IBIT, GRAL, PLBY, BNR, IAU Q4 2024 6 $245.9M IBIT, GRAL, ETHA, PLBY, BNR Q3 2024 4 $154.5M IBIT, GRAL, OMIC, IAU Q2 2024 4 $136.8M IBIT, IAU, GRAL, NXE Q1 2024 4 $131.5M IBIT, IAU, NXE, OXY